Hybridoma Selection

Screen Smarter.

Hybridoma technology enables the creation of immortalized cells that secrete monoclonal antibodies by fusing B cells with myeloma cells. Traditionally, identifying the right antibody-producing clones is time-consuming and labor-intensive.

tANCHORed displayed antigens transform this process by allowing direct, cell-based screening of secreted antibodies. By capturing only high-affinity binders at the surface, this approach enables rapid, specific isolation of productive hybridomas — accelerating the selection process by up to 4× while reducing background and false positives.

Target the best. Skip the rest.

Select Faster.

Reference

Ivanusic D., Madela K., Burghard H., Holland G., Laue M., Bannert N. tANCHOR: a novel mammalian cell surface peptide display system. Biotechniques. 2021 Jan;70(1):21-28.